Dr. Cora N. Sternberg of the San Camillo and Forlanini Hospitals in Rome and study coordinator of EORTC trial 30994, presented the long term results of that trial at ASCO 2014 in Chicago. The results lend new support to use of immediate cisplatin-based chemotherapy following surgical resection. An overview of the trial results were reported in the 03 June 2014 ASCO Daily News.
Can RA-223 improve on Enzalutamide efficacy in patients with early castration resistant prostate cancer?
Can abiraterone and radiotherapy improve survival for patients with metastatic prostate cancer treated with ADT?